Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XJ
- Chemical substanceL01XJ03Glasdegib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Spain
AEMPS · 2 registrations
Netherlands
CBG-MEB · 2 registrations
At a glance
- ATC code
- L01XJ03
- Registers
- 6
- Registrations
- 9
- With their own page
- 9
- Companies
- 3
All medicines with Glasdegib
Human medicines from every register that match Glasdegib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Daurismo | United States | 100MG BASE, 25MG BASE | tablet | Marketed | Pfizer |
| Daurismo | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Daurismo 100 MG Comprimidos Recubiertos con Pelicula | Spain | 131,062 mg | comprimido recubierto con película | Authorised | Pfizer Europe Ma Eeig |
| Daurismo 100 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Pfizer Europe MA EEIG | |
| Daurismo 25 MG Comprimidos Recubiertos con Pelicula | Spain | 32,765 mg | comprimido recubierto con película | Authorised | Pfizer Europe Ma Eeig |
| Daurismo 25 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Pfizer Europe MA EEIG | |
| Daurismo | Canada | 100 MG | Tablet | Marketed | Pfizer Canada Ulc |
| Daurismo | Canada | 25 MG | Tablet | Marketed | Pfizer Canada Ulc |
| Daurismo | Croatia | Authorised |